CRP and cancer: It is also interesting to look at whether suPAR levels correlate with the general inflammation markers such as C-reactive protein (CRP), neutrophil count, and the neutrophil-lymphocyte ratio (NLR) in cancer patients, which may help to predict whether elevated suPAR is mainly derived from tumor cells or immune cells.